ZBD(SH:603567) Zheng Quan Zhi Xing·2025-07-16 09:26Core Viewpoint - The company, Heilongjiang Zhenbaodao Pharmaceutical Co., Ltd., has announced a guarantee for its associate company, Anhui Jiuzhou Fangyuan Pharmaceutical Co., Ltd., amounting to RMB 200 million to support its bank financing needs [1][2]. Summary by Sections Guarantee Overview - The guarantee is provided to Anhui Jiuzhou Fangyuan for a maximum amount of RMB 200 million, with a guarantee period of 12 months [1][4]. - The guarantee is structured as a joint liability guarantee, and there is a counter-guarantee from other shareholders of Anhui Jiuzhou Fangyuan [2][4]. Internal Decision-Making Process - The company's board of directors approved the guarantee proposal on June 15, 2025, with a majority of directors in favor [2]. - The shareholders' meeting on June 25, 2025, also approved the guarantee amount of RMB 200 million [2]. Basic Information of the Guaranteed Entity - Anhui Jiuzhou Fangyuan is a company in which the company holds a 34.82% stake, with other major shareholders holding significant portions as well [3]. - The company was established on May 7, 2013, and has a registered capital of RMB 324.76 million [3]. Main Content of the Guarantee Agreement - The guarantee covers all debts including principal, interest, penalties, and any costs incurred in enforcing the creditor's rights [4]. - The total amount of external guarantees provided by the company is RMB 1.791 billion, which is 22.96% of the company's latest audited net assets [5]. Necessity and Reasonableness of the Guarantee - The guarantee is deemed necessary to support the operational needs of Anhui Jiuzhou Fangyuan, which has a stable operational status and good credit record [4][5]. - The board believes that the risks associated with the guarantee are controllable and will not harm the interests of the company or its shareholders [5].